Central Line-Associated Bloodstream Infection
June 21, 2012
Dr. William Jarvis, Jason and Jarvis Associates, L.L.C.
Dr. Jarvis is an acknowledged world leader in hospital-acquired (nosocomial) infection control. He is a highly published expert in infectious diseases, infection control, epidemiology, public health, and pediatrics. His areas of most intense expertise include antimicrobial-resistant bacterial infections (esp. methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant enterococcus [VRE], or vancomycin intermediate-resistant or resistant S. aureus [VISA or VRSA]), surgical site infections, fungal infections, bloodstream infections, surveillance, outbreak investigations, infections associated with medical devices or procedures, national surveillance systems (National Nosocomial Infections Surveillance [NNIS] system), and patient safety. Dr. Jarvis has published over 500 articles, book chapters, and editorials on these topics.
Claudio Martin, MD, FRCPC (Collaborative Chair)
Intensivist, London Health Sciences Centre, Critical Care Trauma Centre; Professor of Medicine and Physiology, University of Western Ontario; Chair/Chief of Critical Care Western
Dr. Martin is a physician with the London Health Sciences Centre, Victoria Campus and an Associate Professor of Medicine and Physiology at The University of Western Ontario. His clinical interests include information systems and critical illness severity scoring. He is involved in the development of a critical care medicine resource site on the Internet.
Learn about the updated Safer Healthcare Now! CLA-BSI Getting Started Kit and its impact on reducing CLA-BSI in the intensive care unit.
Participate in a dialogue about some of the controversies and implementation of "optional" recommendations in the most recent Centers for Disease Control and Prevention (CDC) and the Society for Healthcare Epidemiology of America (SHEA) guidelines.